Co-evolution of host and pathogen: HIV as a model. Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL

Similar documents
On an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures

Lecture 11. Immunology and disease: parasite antigenic diversity

Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire

How HIV Causes Disease Prof. Bruce D. Walker

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED

Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background

CS229 Final Project Report. Predicting Epitopes for MHC Molecules

Micro 301 HIV/AIDS. Since its discovery 31 years ago 12/3/ Acquired Immunodeficiency Syndrome (AIDS) has killed >32 million people

Foreign antigens in human cancers

Antigen Recognition by T cells

Received 25 April 2002/Accepted 21 May 2002

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Grade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period

Eur. J. Immunol : Antigen processing 2295

Human immunodeficiency viruses HIV-1

SUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

Received 16 September 2010/Accepted 9 November 2010

Antigen Presentation to T lymphocytes

Workshop presentation: Development and application of Bioinformatics methods

Human Immunodeficiency Virus

HIV Pathogenesis and Natural History. Peter W. Hunt, MD Associate Professor of Medicine University of California San Francisco

7.012 Quiz 3 Answers

Epitope discovery. Using predicted MHC binding CENTER FOR BIOLOGICAL SEQUENCE ANALYSIS

Convolutional and LSTM Neural Networks

Genome and other Sequence Information from Primate Models of HIV Infection

Finding protein sites where resistance has evolved

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017

Received 19 September 2007/Accepted 21 November 2007

Are we targeting the right HIV determinants?

The Immune Epitope Database Analysis Resource: MHC class I peptide binding predictions. Edita Karosiene, Ph.D.

Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Supporting Information

Supplementary Materials

S. No Topic Class No Date

SUPPLEMENTARY INFORMATION

Host Genomics of HIV-1

Vaccine Design: A Statisticans Overview

HIV Anti-HIV Neutralizing Antibodies

Should There be Further Efficacy Testing of T-T cell Based Vaccines that do not Induce Broadly Neutralizing Antibodies?

2005 LANDES BIOSCIENCE. DO NOT DISTRIBUTE.

An Evolutionary Story about HIV

Evolution of the Virulent Primary Isolate, SIV/DeltaB670, in vivo, Implications for Study Design and Antiviral Therapies

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS

Outline. How archaics shaped the modern immune system. The immune system. Innate immune system. Adaptive immune system

HIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES. Elizabeth Susan Russell

Protein Structure and Computational Biology, Good morning and welcome!

Challenges in Designing HIV Env Immunogens for Developing a Vaccine

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

RAISON D ETRE OF THE IMMUNE SYSTEM:

Evidence of HIV-1 Adaptation to HLA- Restricted Immune Responses at a Population Level. Corey Benjamin Moore

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

IMMUNOINFORMATICS: Bioinformatics Challenges in Immunology

Immunodeficiency. (2 of 2)

Copyright 2015 David F. Boyd

Immune Epitope Database NEWSLETTER Volume 6, Issue 2 July 2009

RAISON D ETRE OF THE IMMUNE SYSTEM:

Nef-mediated tetherin antagonism

EBV infection B cells and lymphomagenesis. Sridhar Chaganti

Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques

SIV ESCAPE FROM IMMUNE RECOGNITION DUE TO SELECTION PRESSURE OF IMMUNODOMINANT CD8+ EPITOPE GAG-CM9 AND TRIM5 RESTRICTION SITES.

6/7/17. Immune cells. Co-evolution of innate and adaptive immunity. Importance of NK cells. Cells of innate(?) immune response

Lecture 2 Evolution in action: the HIV virus

SYSTEMS BIOLOGY APPROACHES TO IDENTIFY MECHANISMS OF IMMUNE MEDIATED PROTECTION TRANSLATING RESEARCH INTO HEALTH

Bachelor Biomedical Sciences Utrecht University. Anouk Schuren

How specific should immunological memory be?

IMMU3903 Immunology in Human Disease 2017

HIV acute infections and elite controllers- what can we learn?

Received 31 March 2011/Accepted 19 July 2011

Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection

cure research HIV & AIDS

UNIFYING VIRAL EVOLUTION AND IMMUNOLOGICAL PATTERNS TO INVESTIGATE RISK OF HIV-1 DISEASE PROGRESSION

HIV-1 acute infection: evidence for selection?

How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response.

The Major Histocompatibility Complex (MHC)

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

Nef-Mediated Enhancement of Virion Infectivity and Stimulation of Viral Replication Are Fundamental Properties of Primate Lentiviruses

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class.

Functional Comparison of Innate Immune Signaling Pathways in Primates

Whole-Genome Characterization of Human and Simian Immunodeficiency Virus Intrahost Diversity by Ultradeep Pyrosequencing

Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection

Human Genome Complexity, Viruses & Genetic Variability

T cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces

Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning

Epidemics 2 (2010) Contents lists available at ScienceDirect. Epidemics. journal homepage:

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

7.014 Problem Set 7 Solutions

Time course of immune response

Lecture 12. Immunology and disease: parasite antigenic diversity. and. Phylogenetic trees

Antigen Presentation to T lymphocytes

The HIV Clock. Introduction. SimBio Virtual Labs

Antigen capture and presentation to T lymphocytes

Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFβ to Degrade APOBEC3 Restriction Factors

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

Investigation of Host and Viral Genetic Factors Influencing HIV-1 Evolution across North America: Implications for Vaccine Design

Irina Maljkovic Berry

VARIATION IN SIX INNATE IMMUNE GENES DOES NOT DETERMINE PROTECTIVE IMMUNITY AGAINST SIV IN RHESUS MACAQUES. Blair Morgan Gleeson

Transcription:

Co-evolution of host and pathogen: HIV as a model Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL c.kesmir@bio.uu.nl

Outline Does HIV adapt to monomorphic human molecules? Polymorphic molecules: What is the mechanism behind different disease outcomes? Can we learn more about which molecules/mechanisms are important in disease induction by studying evolution of SIV in African monkeys?

Antigen processing and presentation (Class I MHC) E. Reits, NKI

How can a pathogen hide from CTL response?

Specificity of molecules NetChop-20S NetChop-Cterm NetMHC

Specificity of the molecules Proteasome TAP MHC TCR 30% 70% 1-5% 0.001% monomorphic monomorphic polymorphic highly diverse Are monomorphic molecules easy targets of escape during HIV infection? Boris Schmid (UU)

Adaptation on single host level Two full HIV genome sequencies (1986 and Escape from strong epitopes: 13 1997) of a long term MHC escapes: 10 survivor Total of 66 non-silent mutations 62 mutations can be associated with CTL responses given the patient MHCs Processing escapes: 7

Adaptation on population level

Why HIV is not evading processing?

Shadowing due to MHC polymorphism X

Conclusions: adaptation to monomorphic molecules? At the population level processing escape mutants do not get fixed because of the shadowing by MHC polymorphism The degeneracy of proteasome and TAP might make make it difficult for HIV to evade antigen processing (we need to analyse more data to be able to say this).

MHC effect on AIDS: Low Risc Carrigton, et al. 2003

MHC effect on AIDS: High Risc Gao, et al. 2001

What is special about Low risc MHC molecules? Rare allele advantage???? Are they differing in their presentation profile? (Targetting different proteins?) Jose' Borghans & Rob de Boer (UU)

HIV epitopes in LANL database B53 is also a high risc allele, but there are not yet enough epitopes known!

Genome-wide predictions Predict MHC binding for Low RH and High RH alleles for all 9mers/10mers Rank for each allele all 9mers/10mers of HIV according to their MHC binding For each HIV protein look at the rank of the best 3 epitopes Is there a significant difference in the rank of 3 best epitopes between low and high RH alleles? Remember: larger proteins have more chance of having high ranking 9mers!

Genome wide predictions

Why targetting p24 is protective? p24 is the capsid protein Expressed in large numbers (>1000 copies per virion) Expressed very early during infection Crucial for the production of new virions --> highly conserved

However... Even elite suppressors of HIV can have mutations in p24 (Barley et al J. Exp. Med. 2006) These mutations come with a high fitness cost: replication capacity is 10-fold lower HIV escapes the host immune response, but heavily crippled The viral load remains very low --> no progression to AIDS

Low Risc MHC target constrained regions of p24 Anne Mølgaard, CBS

Conclusions: MHC effect on adaptation of HIV Immune selection pressure can cause escape mutants with high fitness cost. Protective MHC molecules are those that target constrained regions of HIV

Primates and SIV/HIV Gordon, et al 2005

Natural host response to SIVsm by S. mangabeys Prevelance upto 60% or more, increasing with age Normal CD4 T cell counts, no signs of hyperactivation High viral loads, however hardly any AIDS SIVsm is not ignored by the host, but a mild T cell response is generated Rhesus macagues infected with modified SIVsm develop AIDS

Chimpanzee and SIV Up to 60% infected with SIVcpz ---> no AIDS 200 chimpanzees so far infected experimentally with HIV1 --> only 1 case of possible AIDS. Low viral loads --> Efficient T cell response??? MHC diversity is much lower compared to human. Especially protective MHC-B has lower diversity. Has been through a severe selection (bottleneck) Common MHC molecules in the chimpanzee population target the same epitopes as human long-term nonprogressors Can we find more signs of adaptation/selection?

Comparative genomics AIDS SIVmac AIDS SIVcpz AIDS HIV-1/2

Comparative analysis Lineage specific genes (~500) difficult to predict the function Look for orthologs in macaques and human that are not existing chimpanzee PanTro2.1 (March 2006) & Ensemble automatic orthology detection (manual check afterwards) There are 312 ortholog groups that are deleted in chimpanzee 153 of these have GO annotations 12 genes are related to immune response and thus our candidates for possible host adaptation

Almost for sure missing in chimpanzee ICEBERG: inhibitor of caspase-1. IL1F7 & ILF18: members of IL1 super family

Some genes are very diverged! Chimp Consortium, Nature, 2005

CCR5 Human Chimp MNYQTSTPYYDIDYGTSEPCQKVNVRQIAARLLPPLYSLVFIFGFVGNVLVVLILIDCKK MDYQVSSPIYDIDYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKR *:**.*:* ***** *******:**:**********************:**:****:**: Human Chimp LKSMTDIYLLNLAISDLLFLLTIPFWAHYAADQWTFGNKMCQLLTGLYYIGFFTGNFFII LKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFII *****************:****:******** ** ***.*********:****:* **** Human Chimp LLTMDRYLAIVHAVSASKARTVTFGVVTSGIAWVVAVLASFPRIIFTRSQKEGSRFTCSP LLTIDRYLAIVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSS ***:********** * ************ *:*****:**:* ********** ::***. Human Chimp HFPPSQHHFWKNFQALKMSVLGLILPLLVMIIGYSAILKTLLRCRNEKKRHKAERLIFVI HFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTI *** **::******:**: :***:******:* **.***************:* ****.* Human Chimp MIVYFLFWAPYNIVLLLSTFQEFFGLNNCNSSNRLDQAMQITETLGMTHCCINPIIYAFV MIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFV *****************.***********.**********:******************* Human Chimp GEKFRRYLSLFFRKHIARRFCKCCPIFQGELPDRVSSVYTRSTGEQEISVAL GEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL *****.** :**:****:******.*** * *:*.***************.*

Conclusions Processing do not shape HIV evolution, because: 1. 2. MHC polymorphism shadow the immune selection pressure on processing The processing is degenerate and thus difficult to escape from MHC alleles targeting constrained regions of HIV are protective. Chimpanzee do not develop AIDS, because they lack some immuno-regulatory genes or HIV/SIV receptors?

Immuno-epidemiology What immune response is controlling HIV? CD8 T cells: MHC polymorphism APOBEC3G: SNPs in 384 AA 8 Toll like receptors: Many SNPs in each gene!

Acknowledgements TBB, Utrecht Boris Schmid Jose' Borghans Rob J. de Boer CBS, DTU, Denmark Anne Mølgaard Ole Lund Morten Nielsen Claus Lundegaard